| Daniel Kenney, PHARMD | |
|
108 Via Estrada Unit B, Laguna Woods, CA 92637-4078 | |
| (619) 994-5527 | |
| Not Available |
| Full Name | Daniel Kenney |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 108 Via Estrada Unit B, Laguna Woods, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235547019 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 27257 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Kenney, PHARMD 108 Via Estrada Unit B, Laguna Woods, CA 92637-4078 Ph: (619) 994-5527 | Daniel Kenney, PHARMD 108 Via Estrada Unit B, Laguna Woods, CA 92637-4078 Ph: (619) 994-5527 |
News Archive
For seven straight years since turning 40, Amy Colton religiously scheduled a mammogram. Every year, the test showed nothing. Two years ago, however, the registered nurse was shocked to discover she was in the latter stages of breast cancer. ... Now she's even more shocked that California's powerful medical lobby is trying to block legislation that would require physicians to tell women if they have the condition, known as "extremely dense breast tissue."
Marijuana is the most prevalent illicit drug used by teenagers and adults around the world. Nearly a third of high school students in the United States report smoking it, and most high schoolers say they have access to the drug.
Freezing abnormal electrical pathways in the hearts of young patients may be a safer alternative to zapping them with powerful radiofrequency probes in order to treat tachycardias and other arrhythmias, according to a new study in the April 5, 2005, issue of the Journal of the American College of Cardiology.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
› Verified 6 days ago
Mr. Frank Vakili, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24330 El Toro Road, Laguna Woods, CA 92637 Phone: 949-830-0391 Fax: 949-830-1141 | |
Renee Lynn Allen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24330 El Toro Rd, Laguna Woods, CA 92637 Phone: 949-830-0391 | |
Dr. Shirin N Moltaji, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24167 Paseo De Valencia, Laguna Woods, CA 92637 Phone: 949-586-3503 | |
Ms. Thuy-vy Hoang Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24330 El Toro Rd, Laguna Woods, CA 92637 Phone: 949-830-0391 Fax: 949-830-1141 | |
William Nguyen Duong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24330 El Toro Rd, Laguna Woods, CA 92637 Phone: 949-830-0391 Fax: 949-830-1141 | |
Dr. Cecilia Tran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24167 Paseo De Valencia, Laguna Woods, CA 92637 Phone: 949-586-3500 Fax: 949-586-2111 | |
Naghmeh Ramezani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24330 El Toro Rd, Laguna Woods, CA 92637 Phone: 949-830-0391 |